Research ArticleCancer

A Mucin 16 bispecific T cell–engaging antibody for the treatment of ovarian cancer

See allHide authors and affiliations

Science Translational Medicine  19 Jun 2019:
Vol. 11, Issue 497, eaau7534
DOI: 10.1126/scitranslmed.aau7534

Article Information

vol. 11 no. 497

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication July 16, 2018
  • Resubmitted December 18, 2018
  • Accepted for publication May 2, 2019
  • .

Author Information

  1. Alison Crawford*,
  2. Lauric Haber,
  3. Marcus P. Kelly,
  4. Kristin Vazzana,
  5. Lauren Canova,
  6. Priyanka Ram,
  7. Arpita Pawashe,
  8. Jennifer Finney,
  9. Sumreen Jalal,
  10. Danica Chiu,
  11. Curtis A. Colleton,
  12. Elena Garnova,
  13. Sosina Makonnen,
  14. Carlos Hickey,
  15. Pamela Krueger,
  16. Frank DelFino,
  17. Terra Potocky,
  18. Jessica Kuhnert,
  19. Stephen Godin,
  20. Marc W. Retter,
  21. Paurene Duramad,
  22. Douglas MacDonald,
  23. William C. Olson,
  24. Jeanette Fairhurst,
  25. Tammy Huang,
  26. Joel Martin,
  27. John C. Lin,
  28. Eric Smith,
  29. Gavin Thurston and
  30. Jessica R. Kirshner
  1. Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
  1. *Corresponding author. Email: alison.crawford{at}regeneron.com

Altmetric

Article usage

Article usage: June 2019 to December 2019

AbstractFullPdf
Jun 201970301141656
Jul 2019562208255
Aug 2019278158147
Sep 2019187132111
Oct 201916210998
Nov 20191656893
Dec 20193913632